Eterna Therapeutics (ERNA)

• Market cap: $9.52M
• 1 day: -3.38%
• 5 days: -17.33%
• 1 month: -30.18%
• 3 months: -40.05%
• 6 months: -47.11%
• Year to date: -58.59%
• 1 year: -92.29%
• 5 years: -93.89%
• 10 years: -72.48%
• Sector: Healthcare
• Industry: Biotechnology

About: Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.

Employees: 6

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

40% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 5

13% more funds holding

Funds holding: 24 [Q4 2024] → 27 (+3) [Q1 2025]

0.91% more ownership

Funds ownership: 1.94% [Q4 2024] → 2.85% (+0.91%) [Q1 2025]

10% less capital invested

Capital invested by funds: $292K [Q4 2024] → $264K (-$28.2K) [Q1 2025]